Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,503,300 | 880,400 | 1,817,200 | 1,724,000 | 1,096,000 |
| Marketable Securities | 3,411,600 | 1,026,900 | 4,632,100 | 11,501,500 | 9,300 |
| Receivables | 3,192,300 | 2,868,100 | 2,899,000 | 2,531,000 | 2,125,400 |
| Inventories | 1,133,100 | 846,900 | 904,500 | 718,000 | 757,500 |
| Other current assets | 0 | 34,000 | 0 | 0 | 4,095,600 |
| TOTAL | $11,126,700 | $6,475,400 | $11,376,700 | $17,857,900 | $8,579,100 |
| Non-Current Assets | |||||
| PPE Net | 1,926,500 | 1,787,000 | 1,785,400 | 1,611,300 | 1,531,300 |
| Investments And Advances | 408,000 | 1,970,600 | 267,900 | 282,100 | 408,700 |
| Intangibles | 80,138,900 | 89,608,700 | 104,511,200 | 108,974,700 | 114,301,400 |
| Other Non-Current Assets | 1,099,010 | 1,945,910 | 400,700 | 260,300 | 10,762,800 |
| TOTAL | $83,572,410 | $95,312,210 | $106,965,200 | $111,128,400 | $127,004,200 |
| Total Assets | $94,699,100 | $101,787,600 | $118,341,900 | $128,986,300 | $135,583,300 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 0 | 4,231,800 | N/A | N/A |
| Accounts payable and accrued liabilities | 6,348,700 | 4,787,200 | 5,541,400 | 5,019,000 | 4,148,600 |
| Other current liabilities | 4,532,500 | 868,300 | N/A | 2,797,900 | 4,089,700 |
| TOTAL | $11,070,700 | $5,727,900 | $9,848,100 | $7,874,700 | $8,292,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 18,116,500 | 22,929,400 | 25,843,500 | 29,970,800 | 40,133,900 |
| aiOther Non-Current Liabilities | 2,945,900 | 2,487,300 | 2,454,200 | 1,965,100 | 2,595,100 |
| TOTAL | $25,432,000 | $30,928,700 | $34,656,700 | $44,911,100 | $50,702,000 |
| Total Liabilities | $36,502,700 | $36,656,600 | $44,504,800 | $52,785,800 | $58,994,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 329,002 | 332,615 | 330,320 | 335,225 | 394,687 |
| Retained earnings | 991,500 | 7,258,900 | 12,957,200 | 18,342,500 | 3,647,500 |
| Other shareholders' equity | 1,230,000 | 1,362,100 | 1,936,700 | -1,030,600 | -496,200 |
| TOTAL | $58,196,400 | $65,131,000 | $73,837,100 | $76,200,500 | $76,589,300 |
| Total Liabilities And Equity | $94,699,100 | $101,787,600 | $118,341,900 | $128,986,300 | $135,583,300 |